NCT03724682 is a NA clinical trial of Carry Life UF device in Chronic Renal Failure, sponsored by Triomed AB.

Who is sponsoring NCT03724682?

NCT03724682 is sponsored by Triomed AB.

What drugs are being tested in NCT03724682?

Interventions in NCT03724682: Carry Life UF device.

What condition does NCT03724682 study?

NCT03724682 studies Chronic Renal Failure.

Is NCT03724682 still recruiting?

NCT03724682 is currently completed. Last updated 28 August 2019.

Last reviewed 2019-08-28 · How we verify

NCT03724682

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Performance Analysis of the Peritoneal Ultrafiltration (PUF) Achieved With the Carry Life® UF

Completed NA Last updated 28 August 2019

What this trial tests

NA trial testing Carry Life UF device in Chronic Renal Failure in 8 participants. Completed in 26 June 2019.

Timeline

1 March 2019

Primary endpoint
26 June 2019

26 June 2019

Quick facts

Lead sponsor	Triomed AB
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	8
Start date	1 March 2019
Primary completion	26 June 2019
Estimated completion	26 June 2019
Sites	3 locations across Sweden

Drugs / interventions tested

Carry Life UF device

Conditions studied

Chronic Renal Failure — all drugs for Chronic Renal Failure →

Sponsor

Triomed AB — full company profile →

Who can join

Eligibility, any sex, with Chronic Renal Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Carry Life UF device performs peritoneal ultrafiltration by adding a concentrated glucose to peritoneal dialysis fluid which has been instilled into the abdomen prior to the connection of the device. Maintaining the glucose concentration in the intraperitoneal fluid results in an increased fluid removal (ultrafiltration). The clinical investigation will evaluate the ultrafiltration achieved with the Carry Life UF device compared to standard peritoneal dialysis (PD) therapy

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of Steady Glucose Concentration Peritoneal Dialysis on Ultrafiltration Volume and Sodium Removal: A Pilot Crossover Trial.
Heimbürger O, Hegbrant J, Martus G, Wilkie M, et al · · 2024 · cited 13× · PMID 37902732 · DOI 10.2215/cjn.0000000000000342

Verify or expand the search:

Other recruiting trials for Chronic Renal Failure

Currently open trials in the same condition.

NCT06227468 — A Clinical Study to Map the HLA Genomic Region in the Greek Population · recruiting
NCT06347029 — Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure P · NA · recruiting
NCT05884866 — A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to B · Phase 2 · recruiting
NCT05353946 — Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure · NA · recruiting

Other Triomed AB trials

Trials by the same sponsor.

NCT05874804 — Carry Life@ UF System Clinical Study · NA · completed
NCT03190018 — A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by C · NA · completed
NCT03128073 — A Feasibility Study of Peritoneal Ultrafiltration With a Wearable Device, CLS UF, That Adds a Glucose-salt Solution to t · NA · completed
NCT02772146 — A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glu · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03724682 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Triomed AB
Last refreshed: 28 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03724682.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing